Covington Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $12.2M | Buy |
147,307
+3,745
| +3% | +$309K | 0.53% | 57 |
|
|
2022
Q2 | $13.7M | Buy |
143,562
+4,897
| +4% | +$466K | 0.55% | 52 |
|
|
2022
Q1 | $16.3M | Buy |
138,665
+24,209
| +21% | +$2.85M | 0.59% | 49 |
|
|
2021
Q4 | $14.8M | Buy |
114,456
+5,635
| +5% | +$730K | 0.51% | 59 |
|
|
2021
Q3 | $12.3M | Buy |
108,821
+6,436
| +6% | +$729K | 0.47% | 64 |
|
|
2021
Q2 | $10.6M | Buy |
102,385
+6,719
| +7% | +$696K | 0.42% | 74 |
|
|
2021
Q1 | $8M | Buy |
95,666
+19,649
| +26% | +$1.64M | 0.34% | 85 |
|
|
2020
Q4 | $6.94M | Buy |
76,017
+1,190
| +2% | +$109K | 0.31% | 91 |
|
|
2020
Q3 | $5.97M | Sell |
74,827
-4,560
| -6% | -$364K | 0.3% | 98 |
|
|
2020
Q2 | $5.49M | Buy |
79,387
+7,870
| +11% | +$544K | 0.31% | 90 |
|
|
2020
Q1 | $4.5M | Sell |
71,517
-1,743
| -2% | -$110K | 0.3% | 96 |
|
|
2019
Q4 | $5.7M | Buy |
73,260
+1,440
| +2% | +$112K | 0.3% | 98 |
|
|
2019
Q3 | $5.27M | Buy |
71,820
+5,940
| +9% | +$435K | 0.3% | 90 |
|
|
2019
Q2 | $4.06M | Buy |
65,880
+17,370
| +36% | +$1.07M | 0.24% | 107 |
|
|
2019
Q1 | $3.09M | Sell |
48,510
-1,110
| -2% | -$70.8K | 0.19% | 117 |
|
|
2018
Q4 | $2.53M | Buy |
49,620
+7,785
| +19% | +$397K | 0.18% | 122 |
|
|
2018
Q3 | $2.43M | Buy |
41,835
+4,680
| +13% | +$272K | 0.15% | 129 |
|
|
2018
Q2 | $1.8M | Buy |
37,155
+465
| +1% | +$22.6K | 0.12% | 143 |
|
|
2018
Q1 | $1.71M | Sell |
36,690
-789
| -2% | -$36.7K | 0.11% | 143 |
|
|
2017
Q4 | $1.41M | Buy |
37,479
+5,370
| +17% | +$202K | 0.09% | 159 |
|
|
2017
Q3 | $1.17M | Buy |
32,109
+2,160
| +7% | +$78.7K | 0.08% | 167 |
|
|
2017
Q2 | $1.18M | Buy |
29,949
+6,675
| +29% | +$263K | 0.1% | 144 |
|
|
2017
Q1 | $730K | Buy |
+23,274
| New | +$730K | 0.06% | 167 |
|